{
    "Trade/Device Name(s)": [
        "Assure Prism multi Blood Glucose Monitoring System",
        "Assure Prism multi Blood Glucose Test Strips"
    ],
    "Submitter Information": "i-SENS, Inc.",
    "510(k) Number": "K151164",
    "Predicate Device Reference 510(k) Number(s)": [
        "K131419"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NBW",
        "CGA"
    ],
    "Summary Letter Date": "July 9, 2015",
    "Summary Letter Received Date": "July 10, 2015",
    "Submission Date": "April 29, 2015",
    "Regulation Number(s)": [
        "21 CFR 862.1345"
    ],
    "Regulation Name(s)": [
        "Glucose test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Fresh capillary whole blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Assure Prism multi blood glucose meter"
    ],
    "Method(s)/Technology(ies)": [
        "Electrochemical biosensor",
        "Amperometric method",
        "Glucose oxidase (Aspergillus sp.)"
    ],
    "Methodologies": [
        "Quantitative measurement"
    ],
    "Submission Type(s)": [
        "System",
        "Test Strip",
        "Meter",
        "Control Solution"
    ],
    "Document Summary": "FDA 510(k) summary for Assure Prism multi Blood Glucose Monitoring System using an electrochemical biosensor for quantitative glucose measurement in capillary whole blood.",
    "Indications for Use Summary": "For quantitative measurement of glucose in fresh capillary whole blood from fingertips and alternative sites; intended for multiple-patient use in professional healthcare settings as an aid to monitor effectiveness of diabetes control, not for neonatal use or for diagnosis/screening of diabetes.",
    "fda_folder": "Clinical Chemistry"
}